Recent developments in nanoparticle based targeted delivery of chemotherapeutics

Current Bioactive Compounds

Volumn 5, Issue 3, 2009, Pages 170-184

  Peach, M Sean ^a,c   Kumbar, Sangamesh G ^a,b   Brown, Justin L ^d   Laurencin, Cato T ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d University of Virginia   (United States)

Author keywords

Active targeting; Cancer; Chemotherapy; Drug delivery; Enhanced permeability and retention effect; Nanoparticles; Nanotechnology; Passive targeting; Xenograft tumor model

Indexed keywords

ANTINEOPLASTIC AGENT; C6 CERAMIDE; CHLORAMBUCIL; CISPLATIN; DOCETAXEL; DOXORUBICIN; GONADORELIN; LIPOSOME; MACROGOL; MULTI WALLED NANOTUBE; NANOPARTICLE; PACLITAXEL; PHOTOSENSITIZING AGENT; PLATINUM DERIVATIVE; POLYCAPROLACTONE; POLYGLACTIN; SINGLE WALLED NANOTUBE; TAMOXIFEN; UNCLASSIFIED DRUG; VASCULOTROPIN; ZINC OXIDE;

BIOCOMPATIBILITY; BIODEGRADABILITY; CANCER CHEMOTHERAPY; CARCINOGENESIS; CONGESTIVE CARDIOMYOPATHY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG TARGETING; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; HYDROPHOBICITY; MALIGNANT NEOPLASTIC DISEASE; NANOTECHNOLOGY; NONHUMAN; OVARY ADENOCARCINOMA; PARTICLE SIZE; PATHOLOGICAL ANATOMY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; ZETA POTENTIAL;

EID: 70449971012     PISSN: 15734072     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340709789054759     Document Type: Review

References (118)

1. American Cancer Society. Cancer Facts & Figures 2008. American Cancer Society Inc: 2008.
2. Kung, H. C., Hoyert, D. L., Xu, J., Murphy, S. L. (2008) Deaths: final data for 2005. Natl. Vital Stat. Rep., 56, 1-120.
3. Folkman, J., Long, D. M., Jr., Becker, F. F. (1963) Growth and metastasis of tumor in organ culture. Cancer, 16, 453-467.
4. Tang, N., Wang, L., Esko, J., Giordano, F. J., Huang, Y., Gerber, H., Ferrara, N., Johnson, R. S. (2004) Loss of HIF-1beta in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell, 6, 485-495. (Pubitemid 39469984)
5. Casanovas, O., Hicklin, D. J., Bergers, G., Hanahan, D. (2005) Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell, 8, 299-309. (Pubitemid 41443415)
6. Pollard, J. W. (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer, 4, 71-78.
7. Greish, K., Fang, J., Inutsuka, T., Nagamitsu, A., Maeda, H. (2003) Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting. Clin. Pharmacokinet., 42, 1089-1105. (Pubitemid 37357647)
8. MacDougall, J. R., Matrisian, L. M. (1995) Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev., 14, 351-362. (Pubitemid 26030973)
9. Rundhaug, J. E. (2005) Matrix metalloproteinases and angiogenesis. J. Cell Mol. Med., 9, 267-285.
10. Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., Maeda, H. (1998) Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Jpn. J. Cancer Res., 89, 307-314. (Pubitemid 28197296)
11. Nathanson, S. D. (2003) Insights into the mechanisms of lymph node metastasis. Cancer, 98, 413-423. (Pubitemid 36828469)
12. Greig, N. H., Daly, E. M., Sweeney, D. J., Rapoport, S. I. (1990) Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain. Cancer Chemother. Pharmacol., , 25, 320-325.
13. Rapoport, S. I. (1992) Drug delivery to the brain: barrier modification and drug modification methodologies. NIDA Res. Monogr., 120, 121-137. (Pubitemid 23095639)
14. Williams, D. (2008) The relationship between biomaterials and nanotechnology. Biomaterials, 29, 1737-1738.
15. Feng, S. S., Zhao, L., Zhang, Z., Bhakta, G. Vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168 h in vivo. Chem. Eng. Sci., 62, 6641-6648.
16. Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., Amidon, G. L. (1997) The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res., 7, 14, 1568-1573.
17. Prabha, S., Zhou, W. Z., Panyam, J., Labhasetwar, V. (2002) Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int. J. Pharm., 244, 105-115.
18. Muller, R. H., Jacobs, C., Kayser, O. (2001) Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev., 47, 3-19. (Pubitemid 32209229)
19. Grabovac, V., Bernkop-Schnurch, A. (2007) Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine. Drug Dev. Ind. Pharm., 33, 767-774. (Pubitemid 47123803)
20. Panyam, J., Zhou, W. Z., Prabha, S., Sahoo, S. K., Labhasetwar, V. (2002) Rapid endo-lysosomal escape of poly(DL-lactide-coglycolide) nanoparticles: implications for drug and gene delivery. FASEB J., 16, 1217-1226. (Pubitemid 34815409)
21. Lavasanifar, A., Samuel, J., Kwon, G. S. (2002) Poly(ethylene oxide)-block-poly(-amino acid) micelles for drug delivery. Adv. Drug Deliv. Rev., 54, 169-190. (Pubitemid 34230440)
22. You, J., Hu, F. Q., Du, Y. Z., Yuan, H. (2007) Polymeric micelles with glycolipid-like structure and multiple hydrophobic domains for mediating molecular target delivery of paclitaxel. Biomacromolecules, 8, 2450-2456. (Pubitemid 47316985)
23. Lockman, P. R., Koziara, J. M., Mumper, R. J., Allen, D. D. J. (2004) Nanoparticle surface charges alter blood-brain barrier integrity and permeability. Drug Target, 12, 635-641. (Pubitemid 40100711)
24. Steiniger, S. C., Kreuter, J., Khalansky, A. S., Skidan, I. N., Bobruskin, A. I., Smirnova, Z. S., Severin, S. E., Uhl, R., Kock, M., Geiger, K. D., Gelperina, S. E. (2004) Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int. J. Cancer, 109, 759-767. (Pubitemid 38405625)
25. Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., Rudzinski, W. E. (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J. Control Release, 70, 1-20. (Pubitemid 32144788)
26. Singh, R., Pantarotto, D., Lacerda, L., Pastorin, G., Klumpp, C., Prato, M., Bianco, A., Kostarelos, K. (2006) Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl. Acad. Sci. USA, 103, 3357-3362. (Pubitemid 43346474)
27. Jin, C., Wu, H., Liu, J., Bai, L., Guo, G. (2007) The effect of paclitaxel-loaded nanoparticles with radiation on hypoxic MCF-7 cells. J. Clin. Pharm. Ther., 32, 41-47. (Pubitemid 46213940)
28. Matsumura, Y., Maeda, H. (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res., 46, 6387-6392. (Pubitemid 17221789)
29. Maeda, H., Ueda, M., Morinaga, T., Matsumoto, T. (1985) Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological properties. J. Med. Chem., 28, 455-461. (Pubitemid 15108801)
30. Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., Jain, R. K. (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA, 95, 4607-4612. (Pubitemid 28207960)
31. Mehta, D., Malik, A. B. (2006) Signaling mechanisms regulating endothelial permeability. Physiol. Rev., 86, 279-367.
32. Maeda, H. (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul., 41, 189-207. (Pubitemid 32520323)
33. Wisse, E., Braet, F., Luo, D., De Zanger, R., Jans, D., Crabbe, E., Vermoesen, A. (1996) Structure and function of sinusoidal lining cells in the liver. Toxicol. Pathol., 24, 100-111. (Pubitemid 26066425)
34. Chen, L. T., Weiss, L. (1973) The role of the sinus wall in the passage of erythrocytes through the spleen. Blood, 41, 529-537.
35. Patel, H. M., Moghimi, S. M. (1998) Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - The concept of tissue specificity. Adv. Drug Deliv. Rev., 32, 45-60.
36. Anand, P., Kunnumakkara, A. B., Newman, R. A., Aggarwal, B. B. (2007) Bioavailability of curcumin: problems and promises. Mol. Pharm., 4, 807-818.
37. Maeda, H. (2001) SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv. Drug Deliv. Rev., 46, 169-185.
38. Qaddoumi, M. G., Ueda, H., Yang, J., Davda, J., Labhasetwar, V., Lee, V. H. (2004) The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers. Pharm. Res., 21, 641-648. (Pubitemid 38457287)
39. Rapopor, N. Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog. Polymer Sci., 32, 962-990.
40. Liu, Z., Chen, K., Davis, C., Sherlock, S., Cao, Q., Chen, X., Dai, H. (2008) Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res., 68, 6652-6660.
41. Devalapally, H., Duan, Z., Seiden, M. V., Amiji, M. M. (2008) Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles. Clin. Cancer Res., 14, 3193-3203.
42. Devalapally, H., Duan, Z., Seiden, M. V., Amiji, M. M. (2007) Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer. Int. J. Cancer, 121, 1830-1838. (Pubitemid 47417304)
43. Ameller, T., Marsaud, V., Legrand, P., Gref, R., Renoir, M. (2003) In vitro and in vivo biologic evaluation of long-circulating biodegradable drug carriers loaded with the pure antiestrogen RU 58668. J. M. Int. J. Cancer, 106, 446-454. (Pubitemid 36870410)
44. He, X., Ma, J., Mercado, A. E., Xu, W., Jabbari, E. (2008) Cytotoxicity of paclitaxel in biodegradable self-assembled coreshell poly(lactide-co- glycolide ethylene oxide fumarate) nanoparticles. Pharm. Res., 25, 1552-1562.
45. Lee, H., Yu, M. K., Park, S., Moon, S., Min, J. J., Jeong, Y. Y., Kang, H. W., Jon, S. (2007) Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo. J. Am. Chem. Soc., 129, 12739-12745. (Pubitemid 350004485)
46. Kaul, G., Amiji, M. (2004) Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model. J. Drug Target, 12, 585-591. (Pubitemid 40100706)
47. Fernandez-Urrusuno, R., Fattal, E., Rodrigues, J. M., Jr., Feger, J., Bedossa, P., Couvreur, P. (1996) Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice. J. Biomed. Mater. Res., 31, 401-408. (Pubitemid 26227058)
48. Owens III, D. E., Peppas, N. A. (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm., 307, 93-102. (Pubitemid 41773257)
49. Panagi, Z., Beletsi, A., Evangelatos, G., Livaniou, E., Ithakissios, D. S., Avgoustakis, K. (2001) Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. Int. J. Pharm., 221, 143-152. (Pubitemid 32524042)
50. Gryparis, E. C., Hatziapostolou, M., Papadimitriou, E., Avgoustakis, K. (2007) Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells. Eur. J. Pharm. Biopharm., 67, 1-8. (Pubitemid 46991325)
51. Gref, R., Luck, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., Muller, R. H. (2000) 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf. B Biointerfaces, 18, 301-313. (Pubitemid 30479870)
52. Liggins, R. T., Burt, H. M. (2002) Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv. Drug Deliv. Rev., 54, 191-202.
53. Xu, P., Tang, H., Li, S., Ren, J., Van Kirk, E., Murdoch, W. J., Radosz, M., Shen, Y. (2004) Enhanced stability of core-surface cross-linked micelles fabricated from amphiphilic brush copolymers. Biomacromolecules, 5, 1736-1744. (Pubitemid 39335209)
54. Yokoyama, M., Opanasopit, P., Okano, T., Kawano, K., Maitani, Y. (2004) Polymer design and incorporation methods for polymeric micelle carrier system containing water-insoluble anti-cancer agent camptothecin. J. Drug Target, 12, 373-384. (Pubitemid 39294835)
55. Yoo, H. S., Lee, E. A., Park, T. G. (2002) Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages. J. Control Release, 82, 17-27.
56. Carrick, S., Parker, S., Wilcken, N., Ghersi, D., Marzo, M., Simes, J. (2005) Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database Syst. Rev., (2), CD003372.
57. Miles, D., von Minckwitz, G., Seidman, A. D. (2002) Combination versus sequential single-agent therapy in metastatic breast cancer. Oncologist, 7(Suppl 6), 13-19. (Pubitemid 36008992)
58. Luqmani, Y. A. (2005) Mechanisms of drug resistance in cancer chemotherapy. Med. Princ Pract., 14(Suppl 1), 35-48. (Pubitemid 41161048)
59. Nooter, K., Stoter, G. (1996) Molecular mechanisms of multidrug resistance in cancer chemotherapy. Pathol. Res. Pract., 192, 768-780. (Pubitemid 26302251)
60. Fujiwara, Y., Kawada, K., Takano, D., Tanimura, S., Ozaki, K., Kohno, M. (2006) Inhibition of the PI3 kinase/Akt pathway enhances doxorubicin-induced apoptotic cell death in tumor cells in a p53-dependent manner. Biochem. Biophys. Res. Commun., 340, 560-566. (Pubitemid 43021784)
61. Bae, Y., Diezi, T. A., Zhao, A., Kwon, G. S. (2007) Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents. J. Control Release, 122, 324-330. (Pubitemid 47404677)
62. Baughman, R. H., Zakhidov, A. A., de Heer, W. A. (2002) Carbon nanotubes - the route toward applications. Science, 297, 787-792.
63. Kam, N. W., Liu, Z., Dai, H. (2006) Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem. Int. Ed Engl., 45, 577-581. (Pubitemid 43121447)
64. Pantarotto, D., Briand, J. P., Prato, M., Bianco, A. (2004) Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem. Commun. (Camb), (1), 16-17. (Pubitemid 38121939)
65. Ajima, K., Yudasaka, M., Murakami, T., Maigne, A., Shiba, K., Iijima, S. (2005) Carbon nanohorns as anticancer drug carriers. Mol. Pharm., 2, 475-480. (Pubitemid 43016388)
66. Iijima, S., Yudasaka, M., Yamada, R., Bandow, S., Suenaga, K., Kokai, F., Takahashi, K. (1999) Nano-aggregates of single-walled graphitic carbon nano-horns. Chem. Phys. Lett, 309, 165-170. (Pubitemid 129556450)
67. Schwartz, R. S. (2004) Paul Ehrlich's magic bullets. N. Engl. J. Med., 350, 1079-1080.
68. Antony, A. C. (1996) Folate receptors. Annu. Rev. Nutr., 16, 501-521.
69. Ross, J. S., Fletcher, J. A. (1998) The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Stem Cells, 16, 413-428. (Pubitemid 28524507)
70. Zhang, Z., Huey Lee, S., Feng, S. S. (2007) Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials, 28, 1889-1899. (Pubitemid 46137995)
71. MacDiarmid, J. A., Mugridge, N. B., Weiss, J. C., Phillips, L., Burn, A. L., Paulin, R. P., Haasdyk, J. E., Dickson, K. A., Brahmbhatt, V. N., Pattison, S. T., James, A. C., Al Bakri, G., Straw, R. C., Stillman, B., Graham, R. M., Brahmbhatt, H. (2007) Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics. Cancer Cell, 11, 431-445. (Pubitemid 46670079)
72. Lee, Y. K. (2006) Preparation and characterization of folic acid linked poly(L-glutamate) nanoparticles for cancer targeting. Macromol. Res., 14, 387-393.
73. Majoros, I. J., Myc, A., Thomas, T., Mehta, C. B., Baker, J. R., Jr. (2006) PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules, 7, 572-579.
74. Slowing, I., Trewyn, B. G., Lin, V. S. (2006) Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J. Am. Chem. Soc., 128, 14792-14793. (Pubitemid 44851603)
75. Shao, N., Lu, S., Wickstrom, E., Panchapakesan, B. (2007) Integrated molecular targeting of IGF1R and HER2 surface receptors and destruction of breast cancer cells using single wall carbon nanotubes. Nanotechnology, 18(31), 31510.
76. Steinhauser, I., Spankuch, B., Strebhardt, K., Langer, K. (2006) Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells. Biomaterials, 27, 4975-4983. (Pubitemid 43866920)
77. Huang, D. M., Hung, Y., Ko, B. S., Hsu, S. C., Chen, W. H., Chien, C. L., Tsai, C. P., Kuo, C. T., Kang, J. C., Yang, C. S., Mou, C. Y., Chen, Y. C. (2005) Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking. FASEB J., 19, 2014-2016. (Pubitemid 41759749)
78. Bae, Y., Jang, W. D., Nishiyama, N., Fukushima, S., Kataoka, K. (2005) Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol. Biosyst., 1, 242-250. (Pubitemid 41442434)
79. Seow, W. Y., Xue, J. M., Yang, Y. Y. (2007) Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles. Biomaterials, 28, 1730-1740. (Pubitemid 46098966)
80. Feazell, R. P., Nakayama-Ratchford, N., Dai, H., Lippard, S. J. (2007) Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design. J. Am. Chem. Soc., 129, 8438-8439. (Pubitemid 47066504)
81. Tkachenko, A. G., Xie, H., Coleman, D., Glomm, W., Ryan, J., Anderson, M. F., Franzen, S., Feldheim, D. L. (2003) Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. J. Am. Chem. Soc., 125, 4700-4701. (Pubitemid 36505350)
82. Rozenzhak, S. M., Kadakia, M. P., Caserta, T. M., Westbrook, T. R., Stone, M. O., Naik, R. R. (2005) Cellular internalization and targeting of semiconductor quantum dots. Chem. Commun. (Camb), (17), 2217-2219.
83. Giacalone, M. J., Gentile, A. M., Lovitt, B. T., Xu, T., Surber, M. W., Sabbadini, R. A. (2006) The use of bacterial minicells to transfer plasmid DNA to eukaryotic cells. Cell Microbiol., 8, 1624-1633. (Pubitemid 44350021)
84. Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., Sun, X., Chen, X., Dai, H. (2007) In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol., 2, 47-52. (Pubitemid 46210038)
85. Yu, B., Yang, J., Li, W. (2007) In vitro capability of multi-walled carbon nanotubes modified with gonadotrophin releasing hormone on killing cancer cells. Carbon, 45, 1921-1927. (Pubitemid 47238077)
86. McDevitt, M. R., Chattopadhyay, D., Kappel, B. J., Jaggi, J. S., Schiffman, S. R., Antczak, C., Njardarson, J. T., Brentjens, R., Scheinberg, D. A. (2007) Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes. J. Nucl. Med., 48, 1180-1189. (Pubitemid 47052659)
87. Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., Langer, R. (2007) Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol., 2, 751-760. (Pubitemid 350223348)
88. Nimjee, S. M., Rusconi, C. P., Sullenger, B. A. (2005) Aptamers: an emerging class of therapeutics. Annu. Rev. Med., 56, 555-583.
89. Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., Langer, R. (2006) Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. USA, 103, 6315-6320.
90. Sahoo, S. K., Labhasetwar, V. (2005) Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol. Pharm., 2, 373-383.
91. Xu, Z., Gu, W., Huang, J., Sui, H., Zhou, Z., Yang, Y., Yan, Z., Li, Y. (2005) In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. Int. J. Pharm., 288, 361-368. (Pubitemid 40038589)
92. Song, L., Li, H., Sunar, U., Chen, J., Corbin, I., Yodh, A. G., Zheng, G. (2007) Naphthalocyanine-reconstituted LDL nanoparticles for in vivo cancer imaging and treatment. Int. J. Nanomedicine, 2, 767-774.
93. Marin, A., Sun, H., Husseini, G. A., Pitt, W. G., Christensen, D. A., Rapoport, N. Y. (2002) Drug delivery in pluronic micelles: effect of high-frequency ultrasound on drug release from micelles and intracellular uptake. J. Control Release, 84, 39-47. (Pubitemid 35223412)
94. Gao, Z., Fain, H. D., Rapoport, N. (2004) Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers. Mol. Pharm., 1, 317-330.
95. Stover, T. C., Kim, Y. S., Lowe, T. L., Kester, M. (2008) Thermoresponsive and biodegradable linear-dendritic nanoparticles for targeted and sustained release of a pro-apoptotic drug. Biomaterials, 29, 359-369.
96. Moghimi, S. M., Hawley, A. E., Christy, N. M., Gray, T., Illum, L., Davis, S. S. (1994) Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes. FEBS Lett., 344, 25-30.
97. Yang, F., Fu de, L., Long, J., Ni, Q. X. (2008) Magnetic lymphatic targeting drug delivery system using carbon nanotubes. Med. Hypotheses, 70, 765-767.
98. Castro, D. J., Saxton, R. E., Lufkin, R. B. (1992) Interstitial photoablative laser therapy guided by magnetic resonance imaging for the treatment of deep tumors. Semin. Surg. Oncol., 8, 233-241.
99. Gurfinkel, M., Thompson, A. B., Ralston, W., Troy, T. L., Moore, A. L., Moore, T. A., Gust, J. D., Tatman, D., Reynolds, J. S., Muggenburg, B., Nikula, K., Pandey, R., Mayer, R. H., Hawrysz, D. J., Sevick-Muraca, E. M. (2000) Pharmacokinetics of ICG and HPPH-car for the detection of normal and tumor tissue using fluorescence, near-infrared reflectance imaging: a case study. Photochem. Photobiol., 72, 94-102.
100. Ren, L., Huang, X. L., Zhang, B., Sun, L. P., Zhang, Q. Q., Tan, M. C., Chow, G. M. (2008) Cisplatin-loaded Au-Au2S nanoparticles for potential cancer therapy: cytotoxicity, in vitro carcinogenicity, and cellular uptake. J. Biomed. Mater. Res. A, 85, 787-796.
101. Habib, A. H., Ondeck, C. L., Chaudhary, P., Bockstaller, M. R., McHenry, M. E. (2008) Evaluation of iron-cobalt/ferrite core-shell nanoparticles for cancer thermotherapy. J. Appl. Phys., 103, 07A307-1-07A307-3.
102. Kam, N. W., O'Connell, M., Wisdom, J. A., Dai, H. (2005) Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl. Acad. Sci. USA, 102, 11600-11605. (Pubitemid 41170772)
103. Liu, Y., Zhang, Y., Wang, S., Pope, C., Chen. W. (2008) Optical behaviors of ZnO-porphyrin conjugates and their potential applications for cancer treatment. Appl. Phys. Lett., 92, 143901.
104. Chen, J., Corbin, I. R., Li, H., Cao, W., Glickson, J. D., Zheng, G. (2007) Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo. J. Am. Chem. Soc., 129, 5798-5799. (Pubitemid 46748467)
105. Boucher, Y., Jain, R. K. (1992) Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res., 52, 5110-5114.
106. Jain, R. K. (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science, 307, 58-62.
107. Brown, E. B., Campbell, R. B., Tsuzuki, Y., Xu, L., Carmeliet, P., Fukumura, D., Jain, R. K. (2001) In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat. Med., 7, 864-868. (Pubitemid 32691644)
108. Gordon, A. N., Fleagle, J. T., Guthrie, D., Parkin, D. E., Gore, M. E., Lacave, A. J. (2001) Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. J. Clin. Oncol., 19, 3312-3322. (Pubitemid 32642183)
109. Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., O'Shaughnessy, J. (2005) Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J. Clin. Oncol., 23, 7794-7803. (Pubitemid 46657376)
110. Danson, S., Ferry, D., Alakhov, V., Margison, J., Kerr, D., Jowle, D., Brampton, M., Halbert, G., Ranson, M. (2004) Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br. J. Cancer, 90, 2085-2091. (Pubitemid 38869710)
111. Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., Watanabe, N. (2004) Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br. J. Cancer, 91, 1775-1781. (Pubitemid 39664964)
112. Gordon, E. M., Lopez, F. F., Cornelio, G. H., Lorenzo, C. C., 3rd, Levy, J. P., Reed, R. A., Liu, L., Bruckner, H. W., Hall, F. L. (2006) Pathotropic nanoparticles for cancer gene therapy Rexin-G IV: three-year clinical experience. Int. J. Oncol., 29, 1053-1064.
113. Kostarelos, K. (2008) The long and short of carbon nanotube toxicity. Nat. Biotechnol., 26, 774-776.
114. Zhao, Y., Xing, G., Chai, Z. (2008) Nanotoxicology: Are carbon nanotubes safe? Nat. Nanotechnol., 3, 191-192.
115. Finn, O. J. (2003) Cancer vaccines: between the idea and the reality. Nat. Rev. Immunol., 3, 630-641.
116. Akagi, T., Wang, X., Uto, T., Baba, M., Akashi, M. (2007) Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives. Biomaterials, 28, 3427-3436. (Pubitemid 46729729)
117. Gordon, E. M., Chan, M. T., Geraldino, N., Lopez, F. F., Cornelio, G. H., Lorenzo, C. C., 3rd, Levy, J. P., Reed, R. A., Liu, L., Hall, F. L. (2007) Le morte du tumour: histological features of tumor destruction in chemo-resistant cancers following intravenous infusions of pathotropic nanoparticles bearing therapeutic genes. Int. J. Oncol., 30, 1297-1307.
118. Murphy, B. A. (2007) Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy. J. Support. Oncol., 5, 13-21.